89bio (ETNB)
US Market

89bio (ETNB) Stock Price & Analysis


ETNB Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$6.58 - $22.93
Previous Close$8.4
Average Volume (3M)1.60M
Market Cap
Enterprise Value$408.30M
Total Cash (Recent Filing)$251.93M
Total Debt (Recent Filing)$24.87M
Price to Earnings (P/E)-4.2
Mar 20, 2024
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.00
Shares Outstanding75,638,516
10 Day Avg. Volume1,068,731
30 Day Avg. Volume1,597,587
Standard Deviation0.26
Financial Highlights & Ratios
Price to Book (P/B)1.55
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-5.20
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-3.22
Price Target Upside247.26% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering8



Ownership Overview

15.59% Mutual Funds
63.57% Other Institutional Investors
20.84% Public Companies and Individual Investors


What was 89bio’s price range in the past 12 months?
89bio lowest stock price was $6.58 and its highest was $22.93 in the past 12 months.
    What is 89bio’s market cap?
    Currently, no data Available
    When is 89bio’s upcoming earnings report date?
    89bio’s upcoming earnings report date is Mar 20, 2024 which is in 108 days.
      How were 89bio’s earnings last quarter?
      89bio released its earnings results on Nov 08, 2023. The company reported -$0.45 earnings per share for the quarter, beating the consensus estimate of -$0.526 by $0.076.
        Is 89bio overvalued?
        According to Wall Street analysts 89bio’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does 89bio pay dividends?
          89bio does not currently pay dividends.
          What is 89bio’s EPS estimate?
          89bio’s EPS estimate is -$0.51.
            How many shares outstanding does 89bio have?
            89bio has 75,638,520 shares outstanding.
              What happened to 89bio’s price movement after its last earnings report?
              89bio reported an EPS of -$0.45 in its last earnings report, beating expectations of -$0.526. Following the earnings report the stock price went down -4.857%.
                Which hedge fund is a major shareholder of 89bio?
                Among the largest hedge funds holding 89bio’s share is RA Capital Management. It holds 89bio’s shares valued at 176M.


                  Company Description


                  89bio, Inc. operates as a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of innovative therapies for nonalcoholic steatohepatitis (NASH), liver and cardio-metabolic diseases. The company was founded on January 01, 2018 and is headquartered in San Francisco, CA.


                  Top 5 ETFs holding ETNB

                  Market Value
                  Smart Score
                  Vanguard Total Stock Market ETF
                  Vanguard Health Care ETF
                  Vanguard U.S. Momentum Factor ETF
                  Purpose Global Innovators Fund
                  Vanguard Russell 3000 ETF
                  Up to five ETFs with an Outperform Smart Score that hold ETNB. The ETFs are listed according to market value of ETNB within the ETF

                  Forecast EPS vs Actual EPS

                  Similar Stocks
                  Price & Change
                  Deciphera Pharmaceuticals
                  Axsome Therapeutics

                  Popular Stocks

                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis